Supriya Lifescience

Trade Spotlight: How should you trade Emcure Pharma, Alkem Laboratories, Indus Towers, Titan, Torrent Pharma, and others on January 9?

The market is expected to consolidate with range-bound trading after the sharp correction. Below are some short-term trading ideas to consider.

Buy Supriya Lifescience; target of Rs 1030: Choice Institutional Equities

Choice Institutional Equities is bullish on Supriya Lifescience has recommended buy rating on the stock with a target price of Rs 1030 in its research report dated November 28, 2025.

Accumulate Supriya Lifescience; target of Rs 850: Deven Choksey

Deven Choksey recommended accumulate rating on Supriya Lifescience with a target price of Rs 850 in its research report dated November 18, 2025.

Supriya Lifesci Standalone September 2025 Net Sales at Rs 199.83 crore, up 20.31% Y-o-Y

Buy Supriya Lifescience; target of Rs 1030: Choice Equity Broking

Choice Equity Broking is bullish on Supriya Lifescience has recommended buy rating on the stock with a target price of Rs 1030 in its research report dated November 12, 2025.

Trade Spotlight: How should you trade Sobha, IDBI Bank, Bharat Electronics, Suzlon Energy, Union Bank of India, BPCL, and others on November 3?

Given the cautious sentiment signaled by momentum indicators, the market may continue consolidating for a few more days. Below are some short-term trading ideas to consider.

Buy Supriya Lifescience; target of Rs 800: Deven Choksey

Deven Choksey is bullish on Supriya Lifescience has recommended buy rating on the stock with a target price of Rs 800 in its research report dated August 22, 2025.

Buy Supriya Lifescience; target of Rs 843: Deven Choksey

Deven Choksey is bullish on Supriya Lifescience has recommended buy rating on the stock with a target price of Rs 843 in its research report dated May 02, 2025.

Supriya Lifesci Standalone March 2025 Net Sales at Rs 184.11 crore, up 16.39% Y-o-Y

Trade Spotlight: How should you trade CAMS, Nippon Life India, Aditya Birla Capital, Indian Hotels, Shyam Metalics, Supriya Life, and others on April 3?

The market is expected to react negatively to the 26% discounted reciprocal tariff on India announced by Donald Trump, but some buying can't be ruled out at lower levels. Below are some trading ideas for the near term.

Buy Supriya Lifescience; target of Rs 740: KR Choksey

KR Choksey is bullish on Supriya Lifescience has recommended buy rating on the stock with a target price of Rs 740 in its research report dated January 28, 2025.

Supriya Lifesci Standalone December 2024 Net Sales at Rs 185.65 crore, up 32.54% Y-o-Y

Trade Spotlight: How should you trade IGL, Tata Steel, Fortis Healthcare, Uno Minda, Supriya Lifescience, NALCO, and others on Thursday?

The market may extend its upward move amid consolidation in the upcoming session, but the "sell on rally" strategy remains valid due to the overall bearish sentiment. Below are some trading ideas for the near term.

Buy Supriya Lifescience; target of Rs 644: KR Choksey

KR Choksey is bullish on Supriya Lifescience has recommended buy rating on the stock with a target price of Rs 644 in its research report dated October 29, 2024.

Supriya Lifesci Standalone September 2024 Net Sales at Rs 166.10 crore, up 18.56% Y-o-Y

Buy Supriya Lifescience; target of Rs 578: KR Choksey

KR Choksey is bullish on Supriya Lifescience has recommended buy rating on the stock with a target price of Rs 578 in its research report dated August 14, 2024.

Supriya Lifesci Standalone June 2024 Net Sales at Rs 160.63 crore, up 21.67% Y-o-Y

Buy Supriya Lifescience; target of Rs 401: KR Choksey

KR Choksey is bullish on Supriya Lifescience has recommended buy rating on the stock with a target price of Rs 401 in its research report dated June 05, 2024.

Supriya Lifesci Standalone March 2024 Net Sales at Rs 158.18 crore, up 11.18% Y-o-Y

Supriya Lifesci Standalone September 2023 Net Sales at Rs 140.10 crore, up 24.89% Y-o-Y

Supriya Lifesci Standalone June 2023 Net Sales at Rs 132.02 crore, up 30.26% Y-o-Y

Supriya Lifesci Standalone March 2023 Net Sales at Rs 142.27 crore, down 21.51% Y-o-Y

Buy Supriya Lifescience; target of Rs 278: KR Choksey

KR Choksey is bullish on Supriya Lifescience has recommended buy rating on the stock with a target price of Rs 278 in its research report dated February 17, 2023.